JABLX | RLEFX | JABLX / RLEFX | |
Total Expense Ratio | 0.62 | 0.39 | 159% |
Annual Report Gross Expense Ratio | 0.62 | 0.39 | 159% |
Fund Existence | 32 years | 10 years | - |
Gain YTD | 4.847 | 8.164 | 59% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.97B | 252B | 4% |
Annual Yield % from dividends | 2.03 | 2.01 | 101% |
Returns for 1 year | 8.70 | 8.07 | 108% |
Returns for 3 years | 39.68 | 35.76 | 111% |
Returns for 5 years | 49.29 | 42.56 | 116% |
Returns for 10 years | 108.84 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
ARKG | 25.39 | 0.22 | +0.87% |
ARK Genomic Revolution ETF | |||
TACK | 28.53 | 0.12 | +0.42% |
Fairlead Tactical Sector | |||
RXL | 41.02 | 0.09 | +0.23% |
ProShares Ultra Health Care | |||
CATF | 48.47 | -0.07 | -0.13% |
American Century California Municipal Bond ETF | |||
AETH | 35.20 | -0.45 | -1.26% |
Bitwise Trendwise Eth & TreasRotStgyETF |